The Food and Drug Administration on Thursday unveiled drugmakers that are limiting access to generic competition by denying access to their products.
The agency released a list of 52 brand name drugs to which generic companies are trying to get access in order to make a cheaper version. However, the generic companies have told the FDA that it is difficult to get access to the samples.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.